GlassScriptPhysician profile
Jacqueline M Rasile
NPI 1922481241
$1,239.66
in general payments reported to CMS, 2019-2025
20 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.78 · 2022: $131 · 2023: $504 · 2024: $315 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,057.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $309.83 | 2021-2025 | Optune, Optune Gio |
| Argenx US, INC. | $165.36 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Medtronic, INC. | $143.88 | 2023-2024 | Mazor X System, Strata |
| Ambu INC. | $117.87 | 2023 | |
| Highridge Medical LLC | $75.61 | 2024-2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Lilly USA, LLC | $70.22 | 2022-2024 | Reyvow, Emgality |
| Ucb, INC. | $49.23 | 2023 | Briviact |
| Abbvie INC. | $44.49 | 2025 | |
| Theragen, INC. | $40.00 | 2025 | Actastim-S |
| Servier Pharmaceuticals LLC | $31.20 | 2024-2025 | |
| Sk Life Science, INC. | $29.65 | 2022 | |
| Monteris Medical Corporation | $24.44 | 2022 | |
| Livanova USA, INC. | $23.26 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Ebi, LLC | $18.79 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Biogen, INC. | $17.81 | 2025 | Vumerity, Tysabri |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Springworks Therapeutics, INC. | $17.08 | 2024 | |
| Jazz Pharmaceuticals INC. | $17.06 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $15.00 | 2021 | |
| Celgene Corporation | $14.68 | 2023 | |
| Zimvie INC. | $14.20 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Rasile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.